Aehr Test Systems
Here’s whether Aehr Test Systems (AEHR) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); RSI 52 — healthy momentum range; strong 1-year return of +258.0%; rising volume confirms the move (1.71x 30d avg). Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-2.12% over 10 days); 3-month momentum negative (-20.4%). Currently 39.7% off its 52-week high. Score: +2/7.
AEHR is holding above its long-term 200-day MA ($51.87) but has slipped below the 50-day MA ($93.17), pointing to short-term weakness in an otherwise intact trend. An RSI of 52.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +258.0% compares to +16.5% for SPY (beat the market by 241.5%). The current 39.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.